| REVVITY INC. DL 1 |
| USA |
| Gesundheit |
| US7140461093 / 850943 |
| PKN (Frankfurt) / RVTY (NYSE) |
| FRA:PKN, ETR:PKN, PKN:GR, NYSE:RVTY |
| S&P500 |
| https://www.revvity.com/ |
|
Revvity Inc. is a global life sciences and diagnostics company that provides health science solutions, technologies, and services for research, development, and clinical testing. Revvity’s current business is organized around two main segments: Lif..
>Volltext.. |
| 11959.41 Mio. EUR |
| 13990.7 Mio. EUR |
| 2510.47 Mio. EUR |
| 743.35 Mio. EUR |
| 205.26 Mio. EUR |
| 1.82 EUR |
| 2880.95 Mio. EUR |
| 882.56 Mio. EUR |
| 541.13 Mio. EUR |
| 0.8 |
| 7.32% |
| -13.98% |
| 0.24 EUR |
| 0.23% |
| 0.23% |
| 17.07.26 - 0.061159004€ 17.04.26 - 0.059066€ >weitere anzeigen... |
| - |
| REVVITY, PERKINELMER, PERKIN ELMER |
| 15.09.26 |
|